Milan: Specialty chemicals maker Anupam Rasayan India Ltd expects pharmaceuticals to account for roughly one-third of group revenue within three years, as it leverages at its newly acquired Bliss GVS Pharma to sell finished drugs and contract manufacturing services in the US and Europe, CEO Gopal Agrawal said on Wednesday.
"Supply chain independence is one of the biggest things customers look for today," Agrawal told PTI in an interview at CPHI Milan, a three-day global pharmaceutical business-to-business event.
